25 Nov

BLOOMBERG _ New Zealand's COVID-19 response rated best in the world

New Zealand is the best place in the world to be in the coronavirus era, according to the new Bloomberg Covid resilience ranking.

From Bloomberg: 

"New Zealand tops the Ranking as of Nov. 23 thanks to decisive, swift action. The small island nation locked down on March 26 before a single Covid-related death had occurred, shutting its borders despite the economy’s heavy reliance on tourism. Early on, Prime Minister Jacinda Ardern’s government said it would target “elimination” of the virus, pouring resources into testing, contact tracing and a centralized quarantine strategy to snuff out local transmission. Having largely achieved it, New Zealanders are basically living in a world without Covid. The nation has seen just a handful of infections in the community in recent months, and live music and large-scale social events are back on. Though its tourism industries are suffering, New Zealand is also well-positioned for a vaccine with two supply deals in place, including one for the shot developed by Pfizer Inc. and Germany’s BioNTech SE"

Link: https://www.bloomberg.com/grap...

Other News

How Biotechs can utilise Australia and New Zealand to extend seasonal clinical trials and rescue studies

Randomised, controlled trials are considered the gold standard in assessing the safety and effectiveness of potential new medicines and therapies.

Read more
The Effect of the Pandemic on locations for conducting clinical trials for Biotechs

Through the spring of 2020, it became evident that the Covid-19 pandemic would have a dual impact on the clinical research sector. While it has provided the opportunity to conduct research for vaccines, treatments, and diagnostic tests for COVID-19; it has also acted as a major disruptive force, halting trials in their tracks, and exacerbating existing fragilities within the sector.

Read more
Global Clinical Trials take advantage of significant Australian R&D tax incentives

Australia and New Zealand are well-established regions for international clinical trials.  Global sponsors understand the region’s ability to deliver quality research outcomes; rapid start-up, recruitment and participant retention, streamlined ethics and regulatory pathways, internationally accepted quality data from world-leading research facilities and Investigators. 

Read more